Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed
- PMID: 2305013
- DOI: 10.1007/BF02244414
Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed
Abstract
Scopolamine hydrobromide was administered by subcutaneous injection to 30 young subjects in a dose of 0.22 mg/70 kg, 0.43 mg/70 kg, or 0.65 mg/70 kg. Treatment effects were compared to placebo on an extensive cognitive assessment battery. Almost all tests in the battery had been previously administered to Alzheimer's disease patients and nondemented elderly subjects. Scopolamine produced deficits on tests of verbal recall, visuospatial recall, visual recognition memory, visuospatial praxis, visuoperceptual function, and psychomotor speed. Immediate memory, language function, object sorting, and frequency of intrusion errors were unaffected. The low dose of scopolamine produced some peripheral anticholinergic signs but did not affect the cognitive measures. The results support the conclusion reached in previous studies that the cognitive profile of scopolamine-injected young subjects is more similar to that of the nondemented elderly than to that of Alzheimer's disease patients.
Similar articles
-
Hypersensitivity to scopolamine in the elderly.Psychopharmacology (Berl). 1992;107(2-3):437-41. doi: 10.1007/BF02245172. Psychopharmacology (Berl). 1992. PMID: 1615141 Clinical Trial.
-
The effects of scopolamine on working memory in healthy young volunteers.Psychopharmacology (Berl). 1988;96(2):145-52. doi: 10.1007/BF00177553. Psychopharmacology (Berl). 1988. PMID: 3148139 Clinical Trial.
-
Effects of scopolamine on matching to sample paradigm and related tests in human subjects.Neuropsychobiology. 2003;48(2):87-94. doi: 10.1159/000072883. Neuropsychobiology. 2003. PMID: 14504417 Clinical Trial.
-
Pharmacologic modelling of Alzheimer's disease.Prog Neuropsychopharmacol Biol Psychiatry. 1986;10(3-5):599-610. doi: 10.1016/0278-5846(86)90030-8. Prog Neuropsychopharmacol Biol Psychiatry. 1986. PMID: 3541054 Review.
-
Scopolamine model of dementia: electroencephalogram findings and cognitive performance.Eur J Clin Invest. 1998 Nov;28(11):944-9. doi: 10.1046/j.1365-2362.1998.00393.x. Eur J Clin Invest. 1998. PMID: 9824440 Review.
Cited by
-
Toxin-Induced Experimental Models of Learning and Memory Impairment.Int J Mol Sci. 2016 Sep 1;17(9):1447. doi: 10.3390/ijms17091447. Int J Mol Sci. 2016. PMID: 27598124 Free PMC article. Review.
-
Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects.Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11816-20. doi: 10.1073/pnas.90.24.11816. Proc Natl Acad Sci U S A. 1993. PMID: 8265632 Free PMC article.
-
Effect of cholinergic neurotransmission modulation on visual spatial paired associate learning in healthy human adults.Psychopharmacology (Berl). 2013 Aug;228(4):673-83. doi: 10.1007/s00213-013-3072-2. Epub 2013 Apr 9. Psychopharmacology (Berl). 2013. PMID: 23568575 Clinical Trial.
-
A Preliminary Pharmacodynamic Study for the Management of Alzheimer's Disease Using Memantine-Loaded PLGA Nanoparticles.AAPS PharmSciTech. 2022 Nov 15;23(8):298. doi: 10.1208/s12249-022-02449-9. AAPS PharmSciTech. 2022. PMID: 36380129
-
Impaired Attentional Processing During Parabolic Flight.Front Physiol. 2021 May 13;12:675426. doi: 10.3389/fphys.2021.675426. eCollection 2021. Front Physiol. 2021. PMID: 34054584 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical